Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Surrozen, Inc. SRZN
$0.55
-$0 (-0.50%)
На 17:49, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
18047640.00000000
-
week52high
3.65
-
week52low
0.34
-
Revenue
12500000
-
P/E TTM
-1
-
Beta
-0.33321300
-
EPS
-0.99000000
-
Last Dividend
0.00000000
-
Next Earnings Date
22 мар 2023 г. в 20:30
Описание компании
Surrozen, Inc., a biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair and regeneration. It is developing tissue-specific antibodies with application across various disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas, and central nervous system. Its products in pipeline include SZN-043 a tissue-specific R-spondin mimetic for the treatment of severe liver disease; and SZN-1326, a bi-specific full-length human antibody that directly modulates Wnt signaling in target tissue by binding to particular Frizzled and LRP receptors that are expressed in intestinal crypts. Surrozen, Inc. was founded in 2015 and is headquartered in South San Francisco, California.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| B of A Securities | Neutral | Buy | 27 мая 2022 г. |
| B of A Securities | Buy | 11 окт 2021 г. | |
| Guggenheim | Buy | 15 сент 2021 г. | |
| Stifel | Buy | 07 сент 2021 г. | |
| JP Morgan | Neutral | 17 окт 2022 г. | |
| B of A Securities | Underperform | Neutral | 17 ноя 2022 г. |
| Guggenheim | Neutral | Buy | 18 ноя 2022 г. |
| JP Morgan | Underweight | Neutral | 29 ноя 2022 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Yeh Wen-Chen | A | 125000 | 125000 | 01 февр 2023 г. |
| Williams Charles O | A | 125000 | 125000 | 01 февр 2023 г. |
| Parker Craig C | A | 9578 | 9578 | 15 дек 2022 г. |
| Yeh Wen-Chen | A | 229138 | 9578 | 15 дек 2022 г. |
| Williams Charles O | A | 9578 | 9578 | 15 дек 2022 г. |
| Vanhove Geertrui | A | 32412 | 9578 | 15 дек 2022 г. |
| BLUTT MITCHELL J MD | D | 0 | 144666 | 14 дек 2022 г. |
| BLUTT MITCHELL J MD | D | 0 | 144666 | 14 дек 2022 г. |
| Williams Charles O | A | 77972 | 77972 | 10 окт 2022 г. |
| Williams Charles O | A | 2433 | 2433 | 10 окт 2022 г. |
Новостная лента
Surrozen to Present at the 41st Annual J.P. Morgan Healthcare Conference
GlobeNewsWire
04 янв 2023 г. в 16:41
SOUTH SAN FRANCISCO, Calif., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Surrozen, Inc. (“Surrozen” or the “Company”) (Nasdaq: SRZN), a company pioneering targeted therapeutics that selectively activate the Wnt pathway for tissue repair and regeneration, will present on January 12, 2023 at 7:30 a.m. Pacific time at the 41st Annual J.P. Morgan Healthcare Conference.
Surrozen, Inc. (SRZN) Upgraded to Buy: Here's What You Should Know
Zacks Investment Research
30 дек 2022 г. в 13:33
Surrozen, Inc. (SRZN) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Surrozen to Present Virtually at the 40th Annual J.P. Morgan Healthcare Conference
GlobeNewsWire
05 янв 2022 г. в 08:00
Surrozen to provide a business update including discussion of pipeline advancements Surrozen to provide a business update including discussion of pipeline advancements
Surrozen to Present at The Piper Sandler 33rd Annual Healthcare Conference
GlobeNewsWire
15 ноя 2021 г. в 08:00
SOUTH SAN FRANCISCO, Calif., Nov. 15, 2021 (GLOBE NEWSWIRE) -- Surrozen, Inc., (NASDAQ: SRZN), a biotechnology company discovering and developing drug candidates to selectively modulate the Wnt pathway, today announced that Craig Parker, Chief Executive Officer, will participate in a fireside chat at the Piper Sandler 33rd Annual Virtual Healthcare Conference at 10:00 a.m. ET on Monday, November 22. Interested parties may access the live webcast via the Investors section of the Surrozen website at www.surrozen.com. A replay of the webcast will be archived on the website.